J. Zajicek, N. Scolding, O. Foster, M. Rovaris, J. Evanson et al., Central nervous system sarcoidosisdiagnosis and management, QJM, vol.92, issue.2, pp.103-117, 1999.
DOI : 10.1093/qjmed/92.2.103
URL : http://qjmed.oxfordjournals.org/cgi/content/short/92/2/103

S. Marangoni, V. Argentiero, and B. Tavolato, Neurosarcoidosis, Journal of Neurology, vol.92, issue.4, pp.488-495, 2006.
DOI : 10.1007/s00415-005-0043-5

D. Tong, N. Manolios, G. Howe, and D. Spencer, New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication, Internal Medicine Journal, vol.45, issue.2, pp.89-94
DOI : 10.1111/j.1445-5994.2011.02612.x

G. Sturfelt, B. Christensson, G. Bynke, and T. Saxne, Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab, J Rheumatol, vol.34, issue.11, pp.2313-2314, 2007.

Y. Mao-draayer and T. Cash, Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitors, Journal of Neurology, vol.17, issue.12, pp.651-653
DOI : 10.1007/s00415-012-6726-9

D. Van-der-stoep, G. Braunstahl, J. Van-zeben, and J. Wouters, P0437 SARCOIDOSIS OCCURRING DURING ANTI TUMOR NECROSIS FACTOR ALPHA THERAPY, NO RELAPSE AFTER RECHALLENGE, European Journal of Internal Medicine, vol.20, issue.12, pp.2847-2848, 2009.
DOI : 10.1016/S0953-6205(09)60457-X

M. Iannuzzi, B. Rybicki, and A. Teirstein, Sarcoidosis, New England Journal of Medicine, vol.357, issue.21, pp.2153-2165, 2007.
DOI : 10.1056/NEJMra071714

F. Bosè, L. Raeli, C. Garutti, E. Frigerio, A. Cozzi et al., Dual role of anti-TNF therapy: Enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues, Clinical Immunology, vol.139, issue.2, pp.164-176, 2011.
DOI : 10.1016/j.clim.2011.01.015

C. Langrish, Y. Chen, W. Blumenschein, J. Mattson, B. Basham et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation, The Journal of Experimental Medicine, vol.71, issue.2, pp.233-240, 2005.
DOI : 10.1038/nri802

E. Russell, F. Luk, S. Manocha, T. Ho, O. Connor et al., Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy, Seminars in Arthritis and Rheumatism, vol.43, issue.1, pp.119-124
DOI : 10.1016/j.semarthrit.2012.10.008

M. Hamon, N. G. Deviere, F. Letournel, F. Dubas, and F. , Neuropathie d??my??linisante au cours d???un traitement par anti-TNF alpha et revue de la litt??rature, Revue Neurologique, vol.163, issue.12, pp.1232-1235, 2007.
DOI : 10.1016/S0035-3787(07)78408-4

J. Jarand, D. Zochodne, L. Martin, and C. Voll, Neurological complications of infliximab, J Rheumatol, vol.33, issue.5, pp.1018-1020, 2006.

R. Seror, C. Richez, C. Sordet, S. Rist, L. Gossec et al., Pattern of demyelination occurring during anti-TNF-?? therapy: a French national survey, Rheumatology, vol.52, issue.5, pp.868-874
DOI : 10.1093/rheumatology/kes375